Switch theme
Sign up to access all valuation multiples
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.
1992
882
LTM Revenue $311M
LTM EBITDA $88.2M
$730M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Clinica Baviera has a last 12-month revenue (LTM) of $311M and a last 12-month EBITDA of $88.2M.
In the most recent fiscal year, Clinica Baviera achieved revenue of $295M and an EBITDA of $87.7M.
Clinica Baviera expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Clinica Baviera valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $311M | XXX | $295M | XXX | XXX | XXX |
| Gross Profit | $311M | XXX | $261M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 88% | XXX | XXX | XXX |
| EBITDA | $88.2M | XXX | $87.7M | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | 30% | XXX | XXX | XXX |
| EBIT | $63.3M | XXX | $62.5M | XXX | XXX | XXX |
| EBIT Margin | 20% | XXX | 21% | XXX | XXX | XXX |
| Net Profit | $45.6M | XXX | $45.2M | XXX | XXX | XXX |
| Net Margin | 15% | XXX | 15% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Clinica Baviera's stock price is EUR 39 (or $44).
Clinica Baviera has current market cap of EUR 625M (or $702M), and EV of EUR 650M (or $730M).
See Clinica Baviera trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $730M | $702M | XXX | XXX | XXX | XXX | $2.81 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Clinica Baviera has market cap of $702M and EV of $730M.
Clinica Baviera's trades at 2.5x EV/Revenue multiple, and 8.3x EV/EBITDA.
Equity research analysts estimate Clinica Baviera's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Clinica Baviera has a P/E ratio of 15.4x.
See valuation multiples for Clinica Baviera and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $702M | XXX | $702M | XXX | XXX | XXX |
| EV (current) | $730M | XXX | $730M | XXX | XXX | XXX |
| EV/Revenue | 2.3x | XXX | 2.5x | XXX | XXX | XXX |
| EV/EBITDA | 8.3x | XXX | 8.3x | XXX | XXX | XXX |
| EV/EBIT | 11.5x | XXX | 11.7x | XXX | XXX | XXX |
| EV/Gross Profit | 2.3x | XXX | n/a | XXX | XXX | XXX |
| P/E | 15.4x | XXX | 15.6x | XXX | XXX | XXX |
| EV/FCF | 38.8x | XXX | 18.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialClinica Baviera's last 12 month revenue growth is 12%
Clinica Baviera's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Clinica Baviera's rule of 40 is 42% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Clinica Baviera's rule of X is 58% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Clinica Baviera and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 12% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | 30% | XXX | XXX | XXX |
| EBITDA Growth | 9% | XXX | 10% | XXX | XXX | XXX |
| Rule of 40 | 42% | XXX | 42% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 58% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 5% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 67% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Clinica Baviera acquired XXX companies to date.
Last acquisition by Clinica Baviera was XXXXXXXX, XXXXX XXXXX XXXXXX . Clinica Baviera acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Clinica Baviera founded? | Clinica Baviera was founded in 1992. |
| Where is Clinica Baviera headquartered? | Clinica Baviera is headquartered in Spain. |
| How many employees does Clinica Baviera have? | As of today, Clinica Baviera has 882 employees. |
| Who is the CEO of Clinica Baviera? | Clinica Baviera's CEO is Mr. Eduardo Baviera Sabater. |
| Is Clinica Baviera publicy listed? | Yes, Clinica Baviera is a public company listed on MAD. |
| What is the stock symbol of Clinica Baviera? | Clinica Baviera trades under CBAV ticker. |
| When did Clinica Baviera go public? | Clinica Baviera went public in 2000. |
| Who are competitors of Clinica Baviera? | Similar companies to Clinica Baviera include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Clinica Baviera? | Clinica Baviera's current market cap is $702M |
| What is the current revenue of Clinica Baviera? | Clinica Baviera's last 12 months revenue is $311M. |
| What is the current revenue growth of Clinica Baviera? | Clinica Baviera revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Clinica Baviera? | Current revenue multiple of Clinica Baviera is 2.3x. |
| Is Clinica Baviera profitable? | Yes, Clinica Baviera is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Clinica Baviera? | Clinica Baviera's last 12 months EBITDA is $88.2M. |
| What is Clinica Baviera's EBITDA margin? | Clinica Baviera's last 12 months EBITDA margin is 28%. |
| What is the current EV/EBITDA multiple of Clinica Baviera? | Current EBITDA multiple of Clinica Baviera is 8.3x. |
| What is the current FCF of Clinica Baviera? | Clinica Baviera's last 12 months FCF is $18.8M. |
| What is Clinica Baviera's FCF margin? | Clinica Baviera's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of Clinica Baviera? | Current FCF multiple of Clinica Baviera is 38.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
